Ex vivo activation and retransfusion of white blood cells. The immunotherapy of cancer.
Hamblin
T J
TJ
Royal Victoria Hospital, Bournemouth, UK.
D000818:Animals; D002469:Cell Separation; D002478:Cells, Cultured; D006801:Humans; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000009:adverse effects / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000187:drug effects / Q000637:transplantation; D017708:Leukocyte Transfusion; D007962:Leukocytes / Q000187:drug effects; D008213:Lymphocyte Activation; D008262:Macrophage Activation; D008264:Macrophages / Q000637:transplantation; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D013602:T-Lymphocytes, Cytotoxic / Q000637:transplantation; D014182:Transplantation, Autologous
D007376:Interleukin-2